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Abstract
Background: Septic encephalopathy is a severe brain dysfunction caused by systemic inflammation
in the absence of direct brain infection. Changes in cerebral blood flow, release of inflammatory
molecules and metabolic alterations contribute to neuronal dysfunction and cell death.
Methods: To investigate the relation of electrophysiological, metabolic and morphological changes
caused by SE, we simultaneously assessed systemic circulation, regional cerebral blood flow and
cortical electroencephalography in rats exposed to bacterial lipopolysaccharide. Additionally,
cerebral glucose uptake, astro- and microglial activation as well as changes of inflammatory gene
transcription were examined by small animal PET using [18F]FDG, immunohistochemistry, and real
time PCR.
Results: While the systemic hemodynamic did not change significantly, regional cerebral blood
flow was decreased in the cortex paralleled by a decrease of alpha activity of the
electroencephalography. Cerebral glucose uptake was reduced in all analyzed neocortical areas, but
preserved in the caudate nucleus, the hippocampus and the thalamus. Sepsis enhanced the
transcription of several pro- and anti-inflammatory cytokines and chemokines including tumor
necrosis factor alpha, interleukin-1 beta, transforming growth factor beta, and monocot
chemoattractant protein 1 in the cerebrum. Regional analysis of different brain regions revealed an
increase in ED1-positive microglia in the cortex, while total and neuronal cell counts decreased in
the cortex and the hippocampus.
Conclusion:  Together, the present study highlights the complexity of sepsis induced early
impairment of neuronal metabolism and activity. Since our model uses techniques that determine
parameters relevant to the clinical setting, it might be a useful tool to develop brain specific
therapeutic strategies for human septic encephalopathy.
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Background
Sepsis and its complications are the leading causes of mor-
tality in intensive care units accounting for 10–50% of
deaths. Up to 71% of septic patients develop potentially
irreversible acute cerebral dysfunction [1-3]. This sepsis-
induced encephalopathy is caused by systemic inflamma-
tion in the absence of direct brain infection and clinically
characterized by slowing of mental processes, impaired
attention, disorientation, delirium or coma. Importantly,
septic encephalopathy (SE) is an early sign of sepsis and
associated with an increased rate of morbidity and mortal-
ity [2].
The pathogenesis of SE is unlikely to be directly induced
by a pathogenic toxin, as similar encephalopathy can
develop as a result of a number of systemic inflammatory
response syndromes that lack an infectious etiology (e.g.
acute pancreatitis, burns etc.). Clinical and experimental
data suggest that a number of factors including the local
generation of pro-inflammatory cytokines, impaired cere-
bral microcirculation, an imbalance of neurotransmitters
and a negative impact of peripheral organ failure contrib-
ute to the development of SE. Additionally, once inflam-
mation persists, increased excitotoxicity and oxidative
stress may further aggravate SE and contribute to neuronal
dysfunction and degeneration (for review see [3]). Of
note, patients with a pre-existing CNS pathology have a
higher risk to develop SE, and a similar predisposing inter-
action has been reported in an animal model of sepsis [4].
Clinically, the electroencephalogram (EEG) serves as an
important diagnostic tool for SE assessment and the
majority of patients shows abnormal EEG recordings [5].
Of note, the degree of EEG pathology correlates well with
the clinical status and prognosis and has been proven
more sensitive than clinical bedside investigation [5].
Likewise, cerebral blood flow (CBF) is another parameter
which is routinely analyzed in patients suffering from SE,
based on the assumption that sepsis exerts profound and
sustained effects on the systemic circulatory function.
However, past studies have yielded controversial results
and to date, the effects of sepsis on CBF as well as neuro-
nal metabolism and activity remain unclear. To further
investigate the relation of potential regional CBF changes,
electroencephalography and cerebral metabolism in
response to SE, we investigated hemodynamic, electro-
physiological and metabolic changes in relation to neu-
roinflammatory markers and neuronal number in a
model of acute SE in rats. Regional cerebral blood flow
was reduced in correlation to EEG frequency 24 h after
intraperitoneal injection of LPS, whereas brain glucose
utilization and neuronal number were reduced concur-
rent with microgliosis and neuroinflammatory response.
Methods
Animals
53 male Wistar rats (Charles River, Sulzfeld, Germany)
weighing 250 – 300 g were housed in groups under stand-
ard conditions at a temperature of 22°C (± 1°C) and a 12
hour light-dark cycle – with free access to standard food
(Altromin, Soest, Germany) and tap water. Animal care
and handling were performed according to the Declara-
tion of Helsinki and approved by local ethical committees
(approval number 50.203.2 BN 33,34/00).
Rats were randomized and received either 10 mg/kg of
LPS (0127:B8, E. coli; Sigma, München, Germany) dis-
solved in 1 ml sodium chloride (0.9%) intraperitoneally
(i. p.) or the vehicle alone. 24 hours after induction of sep-
sis, animals were anaesthetized with a combination of
ketamine (80 mg/kg) and xylazine (10 mg/kg). The tra-
chea was cannulated to facilitate respiration and rectal
temperature was maintained at 37°C using a heating
blanket. The femoral artery was exposed and catheterized
with a polyethylene tube connected to a pressure trans-
ducer for continuous recording of arterial blood pressure
and heart rate (Harvard Apparatus, March-Hugstetten,
Germany). The head was fixed in a stereotactic frame and
four stainless steel skull screws were placed epidurally,
two electrodes per parietal bone at bregma coordinates 0
mm and -6.5 mm, 4 mm from the midline. A reference
electrode was placed on the anterior midline over the
frontal sinus. All electrodes were connected through insu-
lated wire with a 2-channel amplifier (Harvard Apparatus,
March-Hugstetten, Germany). Electrical brain activity was
amplified (× 10 000 – 20 000), digitized and transferred
to a PC for storage and further analysis. EEG was recorded
for 15 – 20 min periods.
After EEG-recording, the screws were removed, and a 5 ×
3 mm large cranial window was drilled (thinning of the
scull until translucency, leaving the dura mater intact),
centered 4 mm lateral and 4 mm caudal to the bregma.
CBF was assessed using a laser flow blood perfusion mon-
itor (PeriFlux 5000, Perimed, Stockholm, Sweden) with a
1.0 mm diameter laser Doppler probe (wavelength 780
μm; probe 407, Perimed, Stockholm Sweden). Local CBF
was measured sequentially at 32 (8 × 4) parietocortical
sites 300 μm apart, just above the dura over the exposed
hemisphere using a micromanipulator as previously pub-
lished [6]. Data were sampled, on average, for 8 s at each
site. Intraarterial pressure curve and CBF signals were
transferred to a PC (Haemodyn, Harvard Apparatus,
March-Hugstetten, Germany). Signals were sampled at
500 Hz with a 12 bit resolution. All experiments were car-
ried out in accordance with the animal welfare guidelines
and laws of the Federal Republic of Germany and were
approved by the local ethics committee.Journal of Neuroinflammation 2008, 5:38 http://www.jneuroinflammation.com/content/5/1/38
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Small animal positron emission tomography (microPET)
microPET was performed on a 32-module quadHIDAC
scanner (Oxford Positron Systems, Weston-on-the-Green,
UK) dedicated to small animal imaging. The scanner has
an effective resolution of 0.7 mm (FWHM) in the transax-
ial and axial directions when using an iterative resolution
recovery reconstruction algorithm [7].
Before the scan, a tail vein catheter was inserted under
short-term isofluorane anesthesia. The conscious rat was
afterwards kept in a restraining device. 40 MBq of 18F-
Fluordeoxyglucose (FDG) in 800 μl 0.9% saline were
injected via the tail vein catheter. Following a 60 min
interval, animals were again anaesthetized using iso-
fluorane and placed in the PET scanner on a heating pad
to maintain normal body temperature. List mode PET
data were acquired for 15 minutes and subsequently
reconstructed into a single image volume with a voxel size
of 0.8 × 0.8 × 0.8 mm3.
Immunohistochemistry
Rats were perfused transcardially using heparanized saline
and brains were subsequently dissected. Serial sagittal sec-
tions were cut (10 μm) from cryo-conserved preserved
hemispheres (Leica Cryostat CM 3050S), embedded in tis-
sue freezing medium (Leica Microsystems #0201-08926,
Nussloch, Germany) and mounted (Microscope Slides
#K0123b, Engelbrecht, Germany). After drying for 30
minutes at room temperature, for fixation slides were
incubated in 4% paraformaldehyde (Roti Histofix 4%
#P087.4, Roth, Karlsruhe, Germany) for 20 minutes.
Blocking of non-specific binding was achieved by one
hour incubation in 5% normal goat serum (Linaris #S-
1000, Wertheim, Germany). Between the steps, slides
were rinsed three times for five minutes in PBST. Immu-
nostaining was performed overnight by incubation at 4°C
with the following primary antibodies: 1.) polyclonal
antibody rabbit-anti-mouse GFAP (1:1000 in 2% normal
goat serum in PBST; DAKO Z0334, Glostrup, Denmark).
2.) monoclonal antibody mouse-anti-rat CD68/ED1
(1:100 in 2% normal goat serum in PBST; Serotec
MCA341G, Düsseldorf, Germany). 3.) monoclonal rabbit
anti mouse NeuN (1:250 in 2% normal donkey serum in
PBS; Clone A60, Chemicon, Temecula, CA). Afterwards
slides were incubated with Alexa Fluor 594-labeled sec-
ondary antibodies for one hour (1:400 in PBST; Invitro-
gen #A11037 & #A11020 Karlsruhe, Germany). For co-
staining with Hoechst Dye 33342 (10 μg/ml; Fluka/
Sigma-Aldrich #14533, Steinheim, Germany) an incuba-
tion time of two minutes was set. Again, slides were rinsed
with PBST between the steps. Finally, the slides were cov-
ered in Mowiol 4–88 (Calbiochem/VWR #475904, Darm-
stadt, Germany) and stored at -20°C in the dark until
microscopy was performed.
Real time PCR
RNA from brain hemispheres were extracted using Trizol
(Life Technologies Invitrogen, Karlsruhe, Germany) using
an Ultra Turrax (IKA Labortechnik, Staufen, Germany).
Total RNA was quantified photometrically and reverse
transcribed using the RevertAid First Strand cDNA Synthe-
sis kit (Fermentas, St. Leon-Rot, Germany) according to
the manufacturer's instructions. Real time qPCR was per-
formed using the StepOnePlus™ Real-Time PCR System
(Applied Biosystems, Foster City, USA). Power SYBR®
Green PCR Master Mix (Applied Biosystems, Foster City,
USA) was used for PCR amplification and real time detec-
tion of PCR products. 1 μl of the RT product correspond-
ing to 40 ng of total RNA, 0.2 μM of each primer and 10
μl of the master mix were mixed and run under the follow-
ing conditions: 95°C for 10 min and 40 cycles of 95°C for
15 s and 60°C for 1 min. Amplification specificity was
checked using a melting curve analysis after PCR. mRNA
expression was normalized to GAPDH. Primers used
were: GAPDH forward ACG ACA GTC CAT GCC ATC AC
and reverse TCC ACC ACC CTG TTG CTG TA, IL-1β for-
ward GCT ACC TAT GTC TTG CCC GTG GAG and revers
GTC CCG ACC ATT GCT GTT TCC TA, IL-4 forward GGA
TGT AACGAC AGC CCT C and revers GAC ACC TCT ACA
GAG TTT CC, IL-6 forward CTT GGG ACT GAT GTT GTT
GA and revers CTC TGA ATG ACT CTG GCT TTG, IL-10
forward CCT GCT CTT ACT GGC TGG AG and reverse
CTG CAG TAA GGA ATC TGT CAG, TNF-α forward AAA
ACT CGA GTG ACA AGC CC and reverse GGT TGA CCT
CAG CGC TGA GC, TGF-β forward TGC GCC TGC AGA
GAT TCA AG and reverse TCT CTG TGG AGC TGA AGC
AG, MCP-1 forward CTG TTG TTC ACA GTT GCT GC and
revers CTG ATC TCA CTT GGT TCT GG and iNOS forward
CCA GAG CAG TAC AAG CTC AC and revers CCA CAA
CTC GCT CCA AGA TC.
Data analysis
Electrophysiological recordings were analyzed using a
moving window analysis with a window length of 16.384
s (8192 data points). Prior to analysis signals were
scanned for movement and recording artifacts using auto-
mated artifact detection. Windows containing constant
signals for more than 100 consecutive points or signal
jumps exceeding 10 standard deviations of a window's
amplitude distribution were discarded.
Arterial pressure signals were decomposed into their
instantaneous frequency and envelope signals using the
Hilbert transform [8] in order to extract heart rate as well
as systolic and diastolic arterial pressure. The shock index
(SI) was determined from the ratio of the heart rate to
systolic blood pressure. Doppler flow signals were aver-
aged over time. EEG signals were subjected to spectral
analysis to extract signal power in different frequency
bands using conventional band definitions (delta 0.5–4Journal of Neuroinflammation 2008, 5:38 http://www.jneuroinflammation.com/content/5/1/38
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Hz, theta 4–8 Hz, alpha 8–13 Hz, beta 13–20 Hz, gamma
20–40 Hz). In order to quantify electroencephalographic
signs of septic encephalopathy in terms of slowing of
oscillatory brain activity, we determined the main EEG
frequency from the maximum of the power spectrum.
All electrophysiological variables extracted in the moving
window analysis were averaged over time (i.e., over differ-
ent windows) for each animal. Results from different
groups (septic animals vs. control animals) were com-
pared using a nonparametric test (two-sided Mann-Whit-
ney test for independent samples). In addition, to address
the question whether electroencephalographic signs of
encephalopathy exhibit dependence on hemodynamic
sepsis parameters, we tested for significant correlation
using a one-sided non-parametric correlation test (Spear-
man's rho).
For analyses of FDG-PET the individual volume data sets
of all ten PET scans were coregistered and an averaged data
set of the control group was calculated on pixel-by-pixel
basis using the MPI-Tool (Advanced Tomo Vision, Ker-
pen, Germany). On this average image regions of interest
(ROI) encompassing neocortex, caudate nucleus, thala-
mus and hippocampus were defined. ROIs were projected
onto the individual data sets of all animals in both study
groups to assess regional FDG uptake. Cerebral glucose
uptake was finally quantified as the count ratio of individ-
ual ROIs and a reference ROI placed in the cerebellum in
each animal.
For immunofluorescence quantification, 5 randomly cho-
sen areas from 10 parallel sections per animal were ana-
lyzed using an Olympus BX61 microscope (Olympus,
Hamburg, Germany) at 10× magnification. Evaluation
was performed by determining the stained area using
Cell^P software (Olympus Soft Imaging Solutions, Müns-
ter, Germany). Statistical analysis was performed using
the Prism 4 Software, (GraphPad, San Diego, CA).
Results
LPS-induced decrease in cortical CBF and alpha activity in 
EEG
Induction of sepsis by intraperitoneal injection of LPS led
to typical sickness behavior (e.g. piloerection, tachypnoe,
social withdrawal) of the mice within 2 h. Five out of 27
animals died within the 24 h observation period after LPS
administration.
There was a non-significant trend towards a hemody-
namic response with a slight increase in heart rate and a
decrease in systolic arterial pressure. In contrast, CBF
measured 24 h after induction of sepsis was significantly
reduced (two-tailed Mann-Whitney test; p = 0.031, Figure
1). Generalized EEG activity tended to be reduced
(increase of delta activity, decrease of activity in other fre-
quency bands and a decrease in the main EEG frequency),
but these changes did not reach the level of statistical sig-
nificance. However, further analysis of single activity
bands revealed that alpha activity was significantly
reduced (two-tailed Mann-Whitney test, p = 0.044). Non-
parametric correlation analysis yielded a significant corre-
lation of cortical blood flow changes and main EEG
frequency (Spearman's rho = 0.304, p = 0.044).
Brain region dependent effect of LPS on glucose uptake
In order to correlate the observed sepsis-induced changes
in CBF and EEG to brain glucose utilization, a marker of
neuronal activity, we assessed cerebral glucose uptake by
18F-fluordeoxyglucose positron emission tomography
([18F]FDG-PET) using a small animal scanner. Twenty-
four h after application of LPS, brain glucose uptake was
reduced in all neocortical areas in the LPS-treated group
compared to the vehicle-treated group (Figure 2), but not
in caudate nucleus, thalamus and hippocampus, suggest-
ing differences in regional vulnerability of different brain
areas in the model used.
Sepsis induces microglial activation and neuronal cell loss
Histological and immunohistochemical procedures
showed that the observed hemodynamic, electrophysio-
logical and metabolic changes in the brain were paralleled
by cell loss in the cortex and hippocampus (Figure 3A and
3B). Additionally, staining for the neuronal marker NeuN
revealed a reduction in the cortical layers and the hippoc-
ampus (Figure 3A and 3B). ED1-reactive microglial cells
were found to be increased in LPS-treated animals, mostly
located in close vicinity to brain blood vessels (Figure 3A
and 3B), but also found with round to oval appearance
scattered throughout the brain parenchyma (data not
shown). We were not able to detect changes in GFAP
immunoreactivity within 24 h after LPS administration
(Figure 3A and 3B).
LPS-induced changes of inflammatory markers
RT-PCR of whole brain lysates showed that intraperito-
neal injection of LPS caused an upregulation of various
pro- and anti-inflammatory mediators within the brain,
with the chemokine monocyte chemoattractant protein 1
(MCP-1) showing the strongest response, followed by the
cytokines interleukin 1 beta (Il-1β), transforming growth
factor beta (TGF-β) and tumor necrosis factor alpha (TNF-
α, Figure 4). In addition inducible nitric oxide synthase
(iNOS) mRNA levels were significantly increased (Figure
4). Several other cytokine levels, including interleukin 4,
interleukin 6 and interleukin 10 were unchanged (Figure
4).Journal of Neuroinflammation 2008, 5:38 http://www.jneuroinflammation.com/content/5/1/38
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Changes of hemodynamics and electroencephalography in response to sepsis induction Sample figure title Figure 1
Changes of hemodynamics and electroencephalography in response to sepsis induction Sample figure title. A, 
Displayed are heart rate (HR), systolic and diastolic arterial pressure (APsys, APdia), shock index (SI) and cerebral blood flow 
(CBF) in vehicle-treated (Con) and LPS-treated rats at 24 h after sepsis induction. While the general cardiovascular parameters 
did not change significantly, CBF was markedly reduced upon LPS exposure. B, Shown is the relative spectral band power and 
the main spectral frequency determined from EEG recordings in vehicle-(Con) and LPS-treated rats 24 h post induction (mean 
± SEM; n = 5 animals/group; two-sided Mann-Whitney test; *p ≤ 0.05, **p ≤ 0.01).Journal of Neuroinflammation 2008, 5:38 http://www.jneuroinflammation.com/content/5/1/38
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Reduction of cerebral glucose uptake in septic encephalopathy Figure 2
Reduction of cerebral glucose uptake in septic encephalopathy. Shown are five representative transversal [18F]FDG-
PET brain slices of rats treated with vehicle (Con, first row) or bacterial lipopolysaccharide (LPS, second row) at 24 h. Corre-
sponding region-of-interest (ROI) masks are displayed below. B, Quantification of [18F]FDG uptake (relative to cerebellar (CB) 
ROI) in vehicle-treated wild-type (Con) and LPS-treated mice (LPS) at 24 h. Significant differences were detected in frontal cor-
tex (FC), parietal cortex (PC) and temporal cortex (TC). In contrast, evaluation of the caudate nucleus (NC), thalamus (THL) 
and hippocampus (HC) did not yield significant results (mean ± SEM; n = 5 animals/group; Student's t test; *p ≤ 0.05, **p ≤ 
0.01).Journal of Neuroinflammation 2008, 5:38 http://www.jneuroinflammation.com/content/5/1/38
Page 7 of 10
(page number not for citation purposes)
Discussion
Sepsis-induced brain dysfunction receives increasing
attention since it directly causes brain damage [9,10] and
correlates well with morbidity and mortality rates of sys-
temic septicemia [2]. Despite this fact, the established
treatment protocols for patients suffering from sepsis or
septic shock lack a specific neuroprotective approach, and
the therapeutic strategy mainly focuses on antimicrobial
drugs and stabilization of cardiovascular parameters. A
prerequisite for the development of improved treatment
Histological analysis of regional LPS induced changes of cell number, micro- and astroglial activation Figure 3
Histological analysis of regional LPS induced changes of cell number, micro- and astroglial activation. A, cell 
number detection by Hoechst 33342 staining and detection of microglial (ED1), neuronal (NeuN), and astroglial (GFAP) immu-
noreactivity in the cortex, 24 h after intraperitoneal application of LPS (LPS) or vehicle (Con). Results are given as percentage 
of immunopositive area. The inset shows a 100× magnification of ED1 positive microglial cells located along a cerebral blood 
vessel. (mean ± SEM; n = 5 animals/group; Student's t test; *p ≤ 0.05, **p ≤ 0.01). B, Quantitative analysis of Hoechst 33342 
staining, ED1, NeuN, and GFAP immunostaining in the cortex (Cx), cerebellum (Cb), thalamus (THL), and hippocampus (HC).Journal of Neuroinflammation 2008, 5:38 http://www.jneuroinflammation.com/content/5/1/38
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approaches is the availability of appropriate animal mod-
els that use tools and techniques relevant to the clinical
setting. In this study we aimed to investigate the mutual
relation of CBF changes, EEG and brain metabolism in
experimentally induced sepsis in rats. We correlated our
findings to inflammatory gene transcription and histolog-
ical analysis of neuronal loss as well as micro- and astro-
glial activation.
Induction of experimental sepsis by LPS did not signifi-
cantly alter systolic blood pressure, heart rate or the calcu-
lated shock index at 24 h. Thus, LPS application did not
cause a profound septic shock syndrome but rather
resulted in slight changes reminiscent of a hyperdynamic
circulatory status which can be observed in early stages of
sepsis, where a marked peripheral vasodilatation is offset
by a substantial increase in cardiac output resulting in lit-
tle or no change of mean arterial blood pressure [11]. Of
note, a mean arterial blood pressure within normal limits
may resemble more closely the situation of patients who
are treated with vasopressants if septic shock is present.
Since the lower limit of cerebral autoregulation in rats is
around 50 mmHg [12,13], it seems unlikely that the CBF
reduction found in the present study is caused by systemic
cardiovascular changes, but rather results from impaired
cerebral microcirculation as recently reported in a similar
model [14].
During human sepsis, EEG changes are common and the
degree of EEG abnormalities is associated with the clinical
severity and the prognosis of SE [5]. Although EEG
changes found in septic rats were not as pronounced as
those described in septic patients [5], our study yielded
comparable results, revealing a generalized slowing of
overall EEG activity and a significant decrease of alpha
activity. These findings confirm previous observations
that LPS-induced sepsis in rats reduced EEG activity in fre-
quency bands ≥ 8 Hz [15] up to 12 h after LPS administra-
tion. In the latter study, a significant increase for
frequencies between 2 and 4 Hz was only observed within
the first 6 h of the experiment, as in our study where no
significant changes of low frequency bands were detected
at 24 h. Interestingly, both serotype and LPS concentra-
tion of the latter study were different to our experimental
protocol, suggesting that the observed effects on EEG
activity are independent from these factors. Paralleling the
LPS-induced EEG changes, microPET in vivo analysis of
cerebral glucose uptake, a metabolic process that has been
linked to neuronal activity in rodents [16], was signifi-
cantly reduced in all cortical areas examined. Explorative
data analysis showed a significant correlation of slowing
of the EEG activity and the decrease of regional CBF found
in septic animals. Reduction of regional CBF might there-
fore, at least in part, be causative for the observed EEG-
changes considered to reflect SE. Alternatively, the induc-
tion of sepsis may have caused substantial brain dysfunc-
tion through both, systemic release [17] as well as local
generation of inflammatory molecules by peripheral
immune cells or locally activated microglia. Such an acti-
vation of microglial cells and astrocytes, which both can
serve as major source of inflammatory molecules has been
well documented in rodent models of SE [18] and brains
of septic patients [9]. In this study, we found that micro-
glial activation in the cortex was associated with a signifi-
cant increase of inflammatory gene transcription of Il-1β,
TNFα, TGF-β, iNOS and MCP-1. In addition, we observed
a reduction of total and neuronal cell number in the cor-
tex and hippocampus, even so we can not exclude that this
may be caused by swelling of the brain. Of note, both
cytokines, TNF-α and Il-1β, have been reported to affect
neuronal function [4,19,20] or survival [21,22]. Similarly,
iNOS-derived NO can down regulate neuronal activity
[23,24], and it has been shown that neuronal viability is
remarkably sensitive to sustained iNOS dependent NO
generation [25-27]. Thus, inflammatory molecules in
concert with inflammation-triggered NO generation may
Reduction of cerebral glucose uptake in septic encephalopa- thy Figure 4
Reduction of cerebral glucose uptake in septic 
encephalopathy. Inflammatory gene transcription was 
studied using cDNA generated from whole brain lysates 24 h 
after intraperitoneal administration of either LPS or vehicle. 
Induction of the indicated pro- and anti-inflammatory 
cytokines was measured by real-time RT-PCR with RNA 
samples prepared from vehicle treated controls and LPS 
treated rats. Triplicate determination was performed for 
each mRNA sample. Gene-expression levels were normal-
ized with GAPDH for each mRNA preparation, and the n-
fold increase in LPS treated animals was calculated by com-
parison with the result obtained in untreated rats. Results 
are the mean ± (+SEM) of five animals per group. (Student's t 
test; *p ≤ 0.05, ***p ≤ 0.001).Journal of Neuroinflammation 2008, 5:38 http://www.jneuroinflammation.com/content/5/1/38
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directly impair neuronal function and cause neurodegen-
eration during SE. Neuronal cell death and a reduction of
neuronal activity – as evidenced by reduced cerebral glu-
cose utilization and EEG slowing, in turn, may negatively
regulate the local CBF since the latter is directly coupled to
the activity of the neighboring neurons [28,29]. It is there-
fore likely that during SE, cerebral microcirculatory fail-
ure, systemic and local inflammation and neuronal
activity mutually influence and promote each other.
Conclusion
Together, the present study highlights the complexity of
these changes and the early impairment of neuronal
metabolism and activity during SE.
Recent data suggest that sepsis causes long-term behavio-
ral changes in rodents [30,31], and minor cognitive
impairment might well be present in human sepsis survi-
vors [3]. Since our model mimics key aspects of human
SE, it might be used to develop brain specific therapeutic
strategies for patients suffering from sepsis
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